Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trelegy vs LABA-LAMA in High Risk GOLD B COPD Patients
NCT06282861Phase 4Terminated
- Sponsor
- Món Clínic
- Start
- Feb 2024
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone in chronic obstructive pulmonary disease (COPD), sponsored by Món Clínic. Started Feb 2024; status: terminated.
02
Drugs
fluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06282861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06282861.